Astria Therapeutics Inc (ATXS) USD0.001

Sell:$7.24Buy:$7.27$0.79 (12.13%)

Prices delayed by at least 15 minutes
Sell:$7.24
Buy:$7.27
Change:$0.79 (12.13%)
Deal now
Prices delayed by at least 15 minutes
Sell:$7.24
Buy:$7.27
Change:$0.79 (12.13%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Astria Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies for allergic and immunological diseases. The Company's lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development for the treatment of hereditary angioedema (HAE), a rare, debilitating and potentially life-threatening disease. Its second program, STAR-0310, is a monoclonal antibody OX40 antagonist in preclinical development for the treatment of atopic dermatitis (AD). The Company owns two patent families directed to STAR-0215. The first patent family is directed to the composition of matter of its product candidate STAR-0215 and its use in treating various plasma kallikrein associated disorders including HAE. In the second patent family, the Company owns one International (PCT) patent application directed to methods of treating various plasma-kallikrein associated disorders, including HAE, with specific dosing regimens of the STAR-0215 antibody.

Key people

Jill C. Milne
President, Chief Executive Officer, Co-Founder, Director
Noah Clauser
Chief Financial Officer
Benjamin Scott Harshbarger
Chief Legal Officer
Andrew Komjathy
Chief Commercial Officer
Andrea Matthews
Chief Business Officer
Christopher J. Morabito
Chief Medical Officer
Kenneth M. Bate
Independent Chairman of the Board
Sunil Agarwal
Director
Joanne T. Beck
Independent Director
Fred Callori
Independent Director
Hugh M. Cole
Independent Director
Click to see more

Key facts

  • EPIC
    ATXS
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US04635X1028
  • Market cap
    $328.45m
  • Employees
    78
  • Shares in issue
    56.43m
  • Exchange
    NASDAQ
  • Index
    TR Equity United States Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.